Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / CALL
-
Number of holders
-
1
-
Total 13F shares, excl. options
-
17,000
-
Shares change
-
-5
-
Total reported value, excl. options
-
$342,000
-
Value change
-
-$1,000
-
Number of sells
-
-1
-
Price
-
$20.14
Significant Holders of VALEANT PHARMACEUTICALS INTL - CALL as of Q2 2016
12 filings reported holding 91911K902 - VALEANT PHARMACEUTICALS INTL - CALL as of Q2 2016.
VALEANT PHARMACEUTICALS INTL - CALL has 1 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 17,000 shares
.
Largest 10 shareholders include FARLEY CAPITAL L.P. (17,000 shares), Cowen Prime Services LLC (0 shares), CITADEL ADVISORS LLC (1,795,700 shares), GROUP ONE TRADING, L.P. (1,503,300 shares), Pentwater Capital Management LP (450,000 shares), ARMISTICE CAPITAL, LLC (240,000 shares), CMT Asset Management Ltd (53,400 shares), Timber Hill LLC (25,000 shares), GLENHILL ADVISORS LLC (22,219 shares), and SIMPLEX TRADING, LLC (8,522 shares).
This table shows the top 1 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.